BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33309037)

  • 1. The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests.
    Netanel C; Goitein D; Rubin M; Kleinbaum Y; Katsherginsky S; Hermon H; Tsaraf K; Tachlytski I; Herman A; Safran M; Ben-Ari Z
    Am J Surg; 2021 Jul; 222(1):214-219. PubMed ID: 33309037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Rezvani R; Ghaffarzadegan K; Nooghabi MJ; Shalchian P; Zangui M; Javid Z; Doaei S; Rajabzadeh F
    Obes Surg; 2019 Aug; 29(8):2585-2592. PubMed ID: 31077025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
    Yeo SC; Ong WM; Cheng KSA; Tan CH
    Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.
    Giannini EG; Coppo C; Romana C; Camerini GB; De Cian F; Scopinaro N; Papadia FS
    Dig Dis Sci; 2018 Jul; 63(7):1946-1951. PubMed ID: 29629490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.
    Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S
    Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity.
    Ooi GJ; Earnest A; Kemp WW; Burton PR; Laurie C; Majeed A; Johnson N; McLean C; Roberts SK; Brown WA
    Int J Obes (Lond); 2018 Nov; 42(11):1900-1911. PubMed ID: 29463916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS).
    Motamedi MAK; Khalaj A; Mahdavi M; Valizadeh M; Hosseinpanah F; Barzin M
    Obes Surg; 2019 Feb; 29(2):511-518. PubMed ID: 30298459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
    Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
    Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes.
    Ruiz-Tovar J; Alsina ME; Alpera MR;
    Acta Chir Belg; 2017 Dec; 117(6):363-369. PubMed ID: 28585487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD.
    Naveau S; Lamouri K; Pourcher G; Njiké-Nakseu M; Ferretti S; Courie R; Tranchart H; Ghinoiu M; Balian A; Prévot S; Perlemuter G; Dagher I
    Obes Surg; 2014 Oct; 24(10):1693-701. PubMed ID: 24841950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bariatric surgery during the evolution of fatty liver-A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography.
    de Barros F; Fonseca ABM
    Clin Obes; 2020 Dec; 10(6):e12393. PubMed ID: 32885600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Shouhed D; Steggerda J; Burch M; Noureddin M
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):797-811. PubMed ID: 28712339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Abdalla MA; Akhlaghi S; Sathyapalan T; Sahebkar A
    Eat Weight Disord; 2022 Mar; 27(2):693-700. PubMed ID: 33999371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of biochemical scores for liver steatosis before and 1 year after sleeve gastrectomy.
    Ruiz-Tovar J; Zubiaga L
    Surg Obes Relat Dis; 2019 Sep; 15(9):1447-1453. PubMed ID: 31204247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.